Breaking News Instant updates and real-time market news.

DVAX

Dynavax

$15.65

0.225 (1.46%)

07:59
01/22/18
01/22
07:59
01/22/18
07:59

Dynavax upgraded to Outperform from Speculative Risk at RBC Capital

RBC Capital analyst Brian Abrahams upgraded Dynavax to Outperform from Speculative Risk with a slightly lower price target of $27 vs. $28 prior. Abrahams says the rating revision is based on his meeting with the management that gave better visibility on Heplisav-B launch, adding that shares appear undervalued over the long term given the low-risk and steady revenue stream of the treatment.

  • 26

    Feb

DVAX Dynavax
$15.65

0.225 (1.46%)

09/12/17
EAMC
09/12/17
NO CHANGE
EAMC
Dynavax weakness a buying opportunity, says Empire
09/15/17
CANT
09/15/17
INITIATION
Target $24
CANT
Overweight
Dynavax initiated with an Overweight at Cantor
Cantor Fitzgerald analyst Elemer Piros started Dynavax Technologies with an Overweight rating and $24 price target. The company is poised for an approval of its novel hepatitis B vaccine candidate for the prevention of HBV in adult patients, the analyst wrote last night in a research note. He assigns a 95% probability of success for Heplisav-B, which has an FDA action date of November 9.
10/16/17
RBCM
10/16/17
NO CHANGE
RBCM
Dynavax selloff from updated ACIP agenda 'unfounded,' says RBC Capital
RBC Capital said the selloff in Dynavax shares from the updated ACIP agenda unfounded DVAX is trading down on unwarranted concerns around an updated ACIP agenda excluding a Heplisav vote. The firm's analyst said the new agenda without the vote for Heplisav is in-line with committee practice and as the ACIP is not allowed to vote on a recommendation until a vaccine has been approved and there is a label to vote on.
11/15/17
BMOC
11/15/17
INITIATION
Target $11
BMOC
Outperform
VBI Vaccines initiated with an Outperform at BMO Capital
BMO Capital analyst Do Kim started VBI Vaccines (VBI) with an Outperform rating and $11 price target. The analyst believes the company's Phase III hepatitis B virus vaccine, Sci-B-Vac, will be preferred over Dynavax's (DVAX) Heplisav-B in the premium-priced HBV vaccine market.

TODAY'S FREE FLY STORIES

ATGE

Adtalem Global Education

$55.70

-0.3 (-0.54%)

16:15
08/16/18
08/16
16:15
08/16/18
16:15
Earnings
Adtalem Global Education sees FY19 revenue growth 3%-4% »

FY19 capital spending is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

AQMS

Aqua Metals

$2.42

0.04 (1.68%)

16:15
08/16/18
08/16
16:15
08/16/18
16:15
Hot Stocks
Aqua Metals CFO Francis Knuettel resigns »

On August 13 Francis…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:15
08/16/18
08/16
16:15
08/16/18
16:15
General news
Breaking General news story  »

Week of 8/15 Fed Balance…

16:15
08/16/18
08/16
16:15
08/16/18
16:15
General news
Breaking General news story  »

Week of 8/6 Money Supply…

TSLA

Tesla

$335.46

-3.2 (-0.94%)

16:14
08/16/18
08/16
16:14
08/16/18
16:14
Periodicals
SEC presses Tesla directors for info on communications with Musk, WSJ says »

Federal regulators are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

MRK

Merck

$68.85

1.49 (2.21%)

, ESALY

Eisai

$0.00

(0.00%)

16:14
08/16/18
08/16
16:14
08/16/18
16:14
Hot Stocks
Merck, Eisai announce FDA approval of LENVIMA capsules »

Eisai Inc. (ESALY) and…

MRK

Merck

$68.85

1.49 (2.21%)

ESALY

Eisai

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 24

    Aug

  • 10

    Sep

  • 12

    Sep

  • 03

    Oct

  • 23

    Oct

  • 29

    Oct

  • 16

    Feb

ATGE

Adtalem Global Education

$55.60

-0.4 (-0.71%)

16:13
08/16/18
08/16
16:13
08/16/18
16:13
Earnings
Breaking Earnings news story on Adtalem Global Education »

Adtalem Global Education…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

ARAY

Accuray

$3.50

0.05 (1.45%)

16:12
08/16/18
08/16
16:12
08/16/18
16:12
Hot Stocks
Accuray CFO Kevin Waters departing October 1, interim CFO appointed »

Accuray CFO Kevin Waters…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

HDSN

Hudson Technologies

$1.76

-0.07 (-3.83%)

16:12
08/16/18
08/16
16:12
08/16/18
16:12
Hot Stocks
Hudson Technologies receives deficiency letter from Nasdaq »

Hudson Technologie…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATGE

Adtalem Global Education

$55.65

-0.35 (-0.63%)

16:11
08/16/18
08/16
16:11
08/16/18
16:11
Earnings
Adtalem Global Education reports Q4 continuing operations EPS 86c, consensus 91c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

ARAY

Accuray

$3.50

0.05 (1.45%)

16:11
08/16/18
08/16
16:11
08/16/18
16:11
Earnings
Accuray sees FY19 revenue $415M-$425M, consensus $398.38M »

Sees adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

AMAT

Applied Materials

$47.19

-0.3 (-0.63%)

16:11
08/16/18
08/16
16:11
08/16/18
16:11
Hot Stocks
Breaking Hot Stocks news story on Applied Materials »

Applied Materials reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

ATAI

ATA Inc.

$6.80

0.06 (0.89%)

16:09
08/16/18
08/16
16:09
08/16/18
16:09
Hot Stocks
ATA Inc. to acquire Beijing Biztour »

ATA Inc announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAT

Mattel

$15.17

-0.11 (-0.72%)

16:08
08/16/18
08/16
16:08
08/16/18
16:08
Hot Stocks
Mattel names Steve Totzke as Chief Commercial Officer »

Mattel announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMAT

Applied Materials

$47.25

-0.24 (-0.51%)

16:08
08/16/18
08/16
16:08
08/16/18
16:08
Hot Stocks
Breaking Hot Stocks news story on Applied Materials »

Applied Materials down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

JWN

Nordstrom

$52.11

0.25 (0.48%)

16:08
08/16/18
08/16
16:08
08/16/18
16:08
Earnings
Nordstrom raises FY18 EPS view to $3.50-$3.65 from $3.35-$3.55 »

Consensus $3.46. Raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

PFNX

Pfenex

$4.77

0.07 (1.49%)

16:08
08/16/18
08/16
16:08
08/16/18
16:08
Hot Stocks
Pfenex CMO Dr. Hubert Chen resigns »

Pfenex announced that Dr.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARAY

Accuray

$3.50

0.05 (1.45%)

16:07
08/16/18
08/16
16:07
08/16/18
16:07
Earnings
Accuray reports Q4 EPS (1c), consensus (2c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

ICFI

ICF International

$80.65

1.15 (1.45%)

16:07
08/16/18
08/16
16:07
08/16/18
16:07
Hot Stocks
ICF International awarded $20M task order from DHIS »

ICF was recently awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZOES

Zoe's Kitchen

$9.48

(0.00%)

16:07
08/16/18
08/16
16:07
08/16/18
16:07
Hot Stocks
Zoe's Kitchen postpones earnings release, conference call until August 17 »

Zoe's Kitchen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

JWN

Nordstrom

$52.13

0.27 (0.52%)

16:06
08/16/18
08/16
16:06
08/16/18
16:06
Earnings
Nordstrom reports Q2 EPS 95c, consensus 84c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

AMAT

Applied Materials

$47.26

-0.23 (-0.48%)

16:06
08/16/18
08/16
16:06
08/16/18
16:06
Earnings
Applied Materials sees FY18 EPS $4.41-$4.49, consensus $4.59 »

Sees FY18 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

EDIT

Editas Medicine

$29.80

0.7 (2.41%)

16:05
08/16/18
08/16
16:05
08/16/18
16:05
Hot Stocks
Editas Medicine announces completion of recombinant DNA committee registration »

Editas Medicine announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

ESRX

Express Scripts

$87.21

0.52 (0.60%)

, CI

Cigna

$187.93

2.48 (1.34%)

16:05
08/16/18
08/16
16:05
08/16/18
16:05
Hot Stocks
Express Scripts urges stockholders to vote in favor of merger with Cigna »

Express Scripts (ESRX)…

ESRX

Express Scripts

$87.21

0.52 (0.60%)

CI

Cigna

$187.93

2.48 (1.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 24

    Aug

  • 12

    Sep

AMAT

Applied Materials

$47.39

-0.105 (-0.22%)

16:04
08/16/18
08/16
16:04
08/16/18
16:04
Earnings
Applied Materials sees Q4 EPS 92c-$1.00, consensus $1.17 »

Sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.